shutterstock 2334008633

MIMETAS and Yamaha Motor sign joint marketing agreement to advance automated human disease model applications for drug development

MIMETAS, a leader in human 3D disease modelling, and Yamaha Motor Co., a developer of the Cell Handler, have singed a strategic joint marketing agreement aimed at advancing therapeutic development using human-relevant models throughout the early drug development pipeline. The collaboration combines MIMETAS’ comprehensive disease modelling and assay development expertise with Yamaha Motor’s state-of-the-art Cell […]

CN Bio Tomasz Kostrzewski

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm study of INI-822 for metabolic liver disease treatment

CN Bio, a leading Organ-on-a-Chip (OOC) company, says its PhysioMimix assay for Non-alcoholic steatohepatitis (NASH) was important for confirmation of efficacy for INI-822 from Inipharm.

shutterstock 1045064908

Verici DX signs global licensing and commercialisation agreement with Thermo Fisher Scientific

Verici Dx, a developer of advanced clinical diagnostics for organ transplant, has signed an exclusive global licensing agreement with Thermo Fisher Scientific to further develop an assay for pre-transplant prognostic testing for risk of early kidney rejection.

Scherm­afbeelding 2024 01 17 om 10.37.58

Automated immunostaining with excellent quality and workload flexibility

By Kellie Madigan The quality and consistency of immunostaining contributes highly to productivity for pathologists and cellular pathology laboratory managers. An evaluation study among key opinion-leaders in this area of healthcare has sought to understand how today’s pathologists perceive staining quality, its impact on their working life, and what the term ‘quality’ covers. This article […]

Worcester CLI 1

Augmenting automation in the clinical laboratory

Running clinical lab tests is a labour-intensive business. Even if the actual test is done by an automated platform, many stages still require manual handling of the specimens, which can limit throughput and allow the potential for errors to occur (we’re only human, after all!). Increasing the amount of automation circumvent these limitations and CLI […]

Scherm­afbeelding 2024 01 16 om 11.19.43

Mycophenolic acid, A glimpse into therapeutic drug monitoring

By Serena Shell, Bheemraj Ramoo, C. Clinton Frazee III and Prof. Uttam Garg Mycophenolic acid is an immunosuppressant administered to patients undergoing various organ transplants. Therapeutic drug monitoring of mycophenolic acid is important to reduce drug toxicity and organ rejection. This is accomplished using several techniques including immunoassays, high-performance liquid chromatography with an ultraviolet detector […]

Figure 2. PFAS cycle

PFAS

By Dr Laura M. Labay and Dr Sherri L. Kacinko The forever contaminants of our generation  PFAS (perfluoroalkyl and polyfluoroalkyl substances) are synthetic chemicals that have a wide range of industrial and manufacturing applications because of their chemical and thermal stability and their hydrophobic and lipophobic characteristics. PFAS are persistent in the environment, bioaccumulate in […]

horiba

HORIBA Medical launches next generation HELO fully automated modular hematology solution

HORIBA Evolutive Laboratory Organisation (HELO) 2.0 embeds advanced hematology technologies to offer flexible, high throughput, high quality analytical performance

Afbeelding1

Ana-Maria Šimundić becomes Director of Global Medical & Clinical Affairs at Greiner Bio-One

On 1 December 2023, Ana-Maria Šimundić took up the newly created position as Director of Global Medical & Clinical Affairs at Greiner Bio-One. In this role, she heads the Global Medical & Clinical Affairs department and will represent Greiner Bio-One in national and international professional circles as well as foster exchange with experts in science […]

alzh

PharmaKure and Universiti Teknologi MARA (UiTM) announce partnership to advance research in Alzheimer’s Disease diagnosis

Research partnership aims to build strong pharma and academic collaborations in sharing data and clinical samples to develop biomarker-based diagnostics for Alzheimer’s Disease